Rho kinase inhibition drives megakaryocyte polyploidization and proplatelet formation through MYC and NFE2

Mauro P Avanzi1, Francine Goldberg, Jennifer Davila

  • 1Platelet Biology Laboratory, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA; Cellular Therapy Laboratory, Hematology Division, Santa Casa Medical School, São Paulo, Brazil.

Insights

Inhibiting Rho kinase (ROCK) signaling boosts megakaryocyte polyploidization and platelet production by promoting the demarcation membrane system (DMS) and downregulating MYC and NFE2 expression.

Area of Science:

  • Hematology
  • Cell Biology
  • Molecular Biology

Background:

  • Megakaryocyte polyploidization and demarcation membrane system (DMS) formation are essential for platelet production.
  • The precise molecular mechanisms governing these processes remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of Rho kinase (ROCK) inhibition on DMS development and proplatelet formation in megakaryocytes.
  • To elucidate the underlying molecular mechanisms, focusing on the expression of transcription factors MYC and NFE2.

Main Methods:

  • Utilized umbilical cord blood-derived megakaryocytes.
  • Administered ROCK inhibitors.
  • Assessed DMS formation, proplatelet formation, and platelet release.
  • Quantified MYC and NFE2 gene expression in mature megakaryocytes.

Main Results:

  • ROCK inhibition significantly enhanced DMS formation.
  • Proplatelet formation and subsequent platelet release were increased following ROCK inhibition.
  • ROCK inhibition led to the downregulation of MYC and NFE2 expression in mature megakaryocytes.
  • Downregulation of MYC and NFE2 correlated positively with enhanced proplatelet formation.

Conclusions:

  • ROCK inhibition promotes megakaryocyte polyploidization, DMS expansion, and proplatelet formation.
  • These effects are mediated, at least in part, by the downregulation of MYC and NFE2 transcription factors late in megakaryocyte maturation.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.3K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K